Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm founded in 2006, with its headquarters in Shanghai and additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early and growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology. Since its inception, Qiming has established itself as a leading investment firm in China, managing four funds with over $1 billion in assets. The firm is known for its strategic focus on fostering innovation and supporting the growth of young, fast-growing enterprises in the Chinese market.
Room3906 Jinmao Tower, 88 Century Boulevard, Shanghai 200121, China

Sam Chen

Associate

Nan Chen

Principal

Anna French

Partner

Jinda Gao

Executive Director

William Hu

Managing Partner

Duane Kuang

Co-Founding Managing Partner

Grace Lee

Partner, Group Chief Operating Officer & Chief Financial Officer

Nisa Leung

Managing Partner

Shuo Mao

vice_president

Mark McDade

Partner

Gary Rieschel

Co-Founding Managing Partner

Amy Tang

Venture Partner

Bonnie Wang

Partner

Shiyu Wang

Partner

Jing Wu

Partner

Kuantai Yeh

Partner

Janet Yu Ph.D

Partner

Alex Zhou

Partner

Past deals in Series B

Hochuen Medical was founded in 2015 by Dr. Robin Liu, an entrepreneur in IVD medical and microfluidics fields, and Eric Zeng, an expert in the electronics OEM industry. The founding management team has an average of more than 20 years of management experience in manufacturing of microfluidic devices, medical disposables, and consumer electronic products. Dr. Robin Liu, co-founder and president of Hochuen Medical, has more than 20 years of experience in the IVD and microfluidic industry, with experience at Motorola, CombiMatrix, GenMark, Beckman Coulter/Danaher, etc. Dr. Liu brings both experience in R&D and production management in the fields of molecular diagnosis, immunoassays, hematology, urinalysis, etc

Gaugene

Series B in 2022
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Boulder Care

Series B in 2022
Boulder Care, Inc. provides telemedicine-based programs for opioid addiction treatment. It offers services to help people recover from opioid addiction using medication, such as buprenorphine and peer support. It also offers patient support, medicine, and psychosocial services. The company serves patients, providers, and organizations. Boulder Care, Inc. was founded in 2017 and is based in Portland, Oregon.

Point One

Series B in 2022
Building the next-gen consumer products!

BUD

Series B in 2022
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

MeetFuture China

Series B in 2022
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

Deep View Technology

Series B in 2022
Beijing Deep View Technology Co., Ltd. engaged in research on 3D computer vision algorithm. The company is based in Beijing, China.

Korro Bio

Series B in 2022
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,

CureGenetics

Series B in 2022
CureGenetics is a Healthcare company.

TUNGEE

Series B in 2021
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

InfStones

Series B in 2021
Infinity Stones is a Silicon Valley-based company that provides cloud management services and security solutions for blockchains. They are blockchain infrastructure architects with proven track records in the industry. Their team is composed of tech leads, management experts, and financial professionals from tech giants like Google, Oracle, and Intel. Infinity Stones is currently hosting nodes for high net worth individuals, institutional investors, foundations, and universities and research institutions. They make sure every investment with us is secure, and investors can expect returns with consistency. It was founded in 2018 and is headquartered in Palo Alto, California.

Wholee

Series B in 2021
Wholee is a member-only zero-markup store.

DPTechnology

Series B in 2021
Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.

Cornerstone Robotics

Series B in 2021
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

Platelet BioGenesis

Series B in 2021
Platelet BioGenesis, Inc. operates as a biotechnology company that produces commercial scale donor-independent human platelets from pluripotent stem cells for clinical application. The company develops a microfluidic bioreactor, which includes generation of functional platelets from human stem cell cultures at scale. It distributes bioreactor platelets to hospitals and blood banks to give to patients worldwide. The company was founded in 2014 and is based in Cambridge, Massachusetts.

Genlight

Series B in 2021
Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.

Okeanos Technology

Series B in 2021
Okeanos offers a custom synthesis and production of special chemical biological reagents and pharmaceutical intermediates for life sciences. The company's main products are modified nucleotides, unnatural amino acids, heterocycle, and fluorescent and labeling reagents. Okeanos offers chemical compounds, pharmaceutical intermediates to the world-famous pharmaceutical companies, such as Pfizer, P&G Novartis, etc and enjoys a good reputation from the customers.

Qingflow

Series B in 2021
Qingflow is a software-as-a-service platform that enables users to create management systems. Qingflow is located in Minhang District, Shanghai.

Sunyur

Series B in 2021
Sunyur is an e-purchase solution provider.

Ventyx Biosciences

Series B in 2021
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets.

Alamar Biosciences

Series B in 2021
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

moodytiger

Series B in 2021
Moody Tiger is an international activewear brand for children. Moody Tiger was founded in 2018.

Gyenno Science

Series B in 2021
Developer of intelligent medical devices designed for treatment of Parkinson and motor dysfunction. With research and development of intelligent monitoring and assistant devices, the company develops systematic systematic solutions to functional disorders for patients with Parkinson and motor dysfunction, enabling patients to monitor their physical activities and facilitate their movements.

Lingyi Zhihui

Series B in 2021
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Kingsware

Series B in 2021
Kingsware specializes in developing a robotic process automation system. It is committed to building an enterprise-level safe robot management platform. Its product follows the design concept of safe, easy-to-use, powerful, stable, and efficient, and the system can be deployed and controlled in a large-scale, highly integrated enterprise complex environment.

Health Biotech

Series B in 2021
Beijing Health Biotech Co. Ltd. develops diagnostic and therapeutic products for diagnosis, treatment, and monitoring of Alzheimer's disease. The company offers diagnostic and therapeutic products, such as vitamins detection, Alzheimer's disease detection and treatment, prostate AA detection, ceramides test, therapeutic drug monitoring, and screening of neonatal genetic metabolic diseases for Alzheimer's disease, cardiovascular disease, urinary disease, genetic metabolic disease, therapeutic drug monitoring, metabolite detection, steroid hormone detection, trace element quantitative detection, vitamin family detection, and microbiological identification. It also offers clinical testing and research services. The company was founded in 2016 and is based in Beijing, China.

Just Medical

Series B in 2021
Just Medical is an artificial orthopedic implant device and system developer.

Hope Medicine

Series B in 2021
Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

Tasogare

Series B in 2021
Tasogare distributes high-quality coffee.

Zion Pharma

Series B in 2021
Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

Alpha Biopharma

Series B in 2021
Alpha Biopharma Inc., a biopharmaceutical company, researches and develops therapeutics. The company develops AZD3759, a small molecule tyrosine kinase inhibitor to treat epidermal growth factor receptor (EGFR) mutation positive non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastases. The company is based in Huangpu, China.

Icosavax

Series B in 2021
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. tHEY were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.

imToken

Series B in 2021
imToken is a feature-rich digital asset wallet enabling multi-chain asset management, DApp browsing and secure, private exchange of value. imToken was established on May 2016, striving to bridge the gap between blockchain technology and general masses with a simple, secure yet powerful digital asset management tool. In the span of 2 years, imToken has expanded our outreach to millions of users from more than 200 countries, becoming the world’s largest Ethereum wallet.

Zhenge Biotech

Series B in 2021
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

Cool Academy

Series B in 2021
Cool College is a Beijing-based software-as-a-service(SaaS) developer for employee training services.

Hangzhou Weier

Series B in 2021
Weier Technology Co., Ltd, also known as Weier Science, designs and develops robots and software. Its human- machine interaction technology caters e-commerce platforms with customer service, sales and marketing, shopping guide, and customer relations management. Weier Technology Co., Ltd was founded in 2016 and is based in Hangzhou, China. Weier Technology operates in the augmented reality and virtual reality industry. The company is based in Shanghai, China.

Singular Medical

Series B in 2021
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Plum

Series B in 2021
Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.

Morewis

Series B in 2021
Morewis is a Enterprise service provider.

Bouffalo Lab

Series B in 2021
Bouffalo Lab designs and develops semiconductor chips. The company offers integrated Wi-Fi chipsets for low-power and high-performance application development and other products. Its products are used in smart homes, cities, manufacturing, robots, and wearable systems, as well as communication equipment and in-vehicle intelligent systems. The company is based in Shanghai, China.

WeRide

Series B in 2021
Guangzhou WeRide Technology Co., Ltd. develops autonomous driving technology for level 4 AD cars. The company also develops own AD hardware solution to fit on cars for surround sensor coverage and full spectrum. The company was founded in 2017 and is headquartered in Guangzhou, China.

Vistel

Series B in 2021
Vistel is a technology-based firm that focuses on the use of artificial intelligence (AI) in the medical field. Vistel was founded in 2016 by Sun Yuhui and Ding Dayong.

Kira Pharma

Series B in 2021
Kira Pharmaceuticals is a developer and researcher of antibody drugs and immunoantibody therapy. The company is mainly engaged in the research, development and production of antibody medicine to treat various diseases, providing healthcare patients with better treatments and therapy.

Elevation Oncology

Series B in 2020
Elevation Oncology, Inc., a biotechnology company, focuses on the development of precision medicines for patients with genomically defined cancers. It offers drugs that inhibit the specific alterations identified as drivers of cancer; and treats solid tumors with the NRG1 genomic fusion. Elevation Oncology, Inc. was formerly known as 14ner Oncology, Inc. The company was incorporated in 2019 and is based in New York, New York.

Talaris Therapeutics

Series B in 2020
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.

Shukun Technology

Series B in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

TUNGEE

Series B in 2020
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

Shukun Technology

Series B in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Luc Therapeutics

Series B in 2020
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. It was founded in 2010 and headquartered in Cambridge, Massachusetts.

Kira Pharma

Series B in 2020
Kira Pharmaceuticals is a developer and researcher of antibody drugs and immunoantibody therapy. The company is mainly engaged in the research, development and production of antibody medicine to treat various diseases, providing healthcare patients with better treatments and therapy.

Bouffalo Lab

Series B in 2020
Bouffalo Lab designs and develops semiconductor chips. The company offers integrated Wi-Fi chipsets for low-power and high-performance application development and other products. Its products are used in smart homes, cities, manufacturing, robots, and wearable systems, as well as communication equipment and in-vehicle intelligent systems. The company is based in Shanghai, China.

Nice Tuan

Series B in 2020
Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.

Chaodian Culture

Series B in 2019
Chaodian Culture

Vongi

Series B in 2019
Vongi is a clinical medicine-based chronic disease patient management platform.

Newsoara

Series B in 2019
Newsoara is a biomedical technology developer that specializes in the development of medical devices.

Genius

Series B in 2019
Genius was founded in February 2017 to focus on the field of K12 artificial intelligence education.

Nice Tuan

Series B in 2019
Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.

61Draw.com

Series B in 2019
Art Class is a children's classroom teaching service provider. The teaching and research team draws on the cutting-edge education concept of the front and the back at home and abroad, and conducts field research in 32 first-tier cities, combined with the test results of hundreds of real-life experiences of the family, to develop a child-friendly nature. Course outline and teaching methods. For the families of children aged 5~12 years old, we provide one-on-one after-school tutoring services for the four major artists in the country. Currently, Lala is mainly using a third-party platform for online instruction, choosing a fixed class and a fixed teacher, because continuity and stability are very important for students to learn skills and aesthetics. However, based on the actual needs of art teaching, painting will also develop its own live teaching system.

dMed

Series B in 2019
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

TigerGraph

Series B in 2019
TigerGraph is a provider of a graph database platform for enterprise applications. It fulfills the true promise and benefits of the graph platform by supporting real-time deep link analytics for enterprises with complex and colossal amounts of data. TigerGraph’s proven technology is used by customers including Alipay, VISA, SoftBank, State Grid Corporation of China, Wish and Elementum. The company supports applications such as IoT, AI, and machine learning to make sense of ever-changing big data. It also provides personalized recommendations, fraud prevention, supply-chain logistics, company knowledge graph, and other features. Founded by Yu Xu, Ph.D. in 2012, TigerGraph is funded by Qiming VC, Baidu, Ant Financial, AME Cloud, Morado Ventures, Zod Nazem, Danhua Capital, and DCVC. TigerGraph is based in Redwood City, CA.

Plum

Series B in 2019
Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.

Insilico Medicine

Series B in 2019
Insilico Medicine, an artificial intelligence company headquartered in Rockville, MD, pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning and meta-learning for generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis and digital medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using the advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.

Insilico Medicine

Series B in 2019
Insilico Medicine, an artificial intelligence company headquartered in Rockville, MD, pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning and meta-learning for generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis and digital medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using the advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.

TUNGEE

Series B in 2019
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

MyHealthTeams

Series B in 2019
MyHealthTeams is a San Francisco-based company building deeply engaging social networks for people living chronic conditions. MyHealthTeams is leading the way in patient engagement, making it easy for consumers to find and connect with others who understand what they face daily because they have been in their shoes. Eric Peacock & Mary Ray co-founded MyHealthTeams in 2012. As of 2019, MyHealthTeams has built and operates over 30 social networks to serve 90% of the addressable chronic condition population in 13 countries.

Chuman

Series B in 2019
Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through the creation, while the APP also supports the dialogue novel reading function.

Dingdong Maicai

Series B in 2019
Dingdong Maicai is a fresh vegetable e-commerce platform, adopting a big data-driven approach, predicting future orders through self-developed data models and multi-dimensional predictions based on historical sales data to reduce the slow-loss loss rate; the varieties are mainly concentrated in vegetables and fresh water. Fish, shrimp, fruit and some organic products,

61Draw.com

Series B in 2019
Art Class is a children's classroom teaching service provider. The teaching and research team draws on the cutting-edge education concept of the front and the back at home and abroad, and conducts field research in 32 first-tier cities, combined with the test results of hundreds of real-life experiences of the family, to develop a child-friendly nature. Course outline and teaching methods. For the families of children aged 5~12 years old, we provide one-on-one after-school tutoring services for the four major artists in the country. Currently, Lala is mainly using a third-party platform for online instruction, choosing a fixed class and a fixed teacher, because continuity and stability are very important for students to learn skills and aesthetics. However, based on the actual needs of art teaching, painting will also develop its own live teaching system.

Pratilipi

Series B in 2019
Pratilipi is a platform which brings readers, writers and their stories together. From the next door neighbour reading stories in the afternoon, to the funny college kid downstairs, millions of people around you are using Pratilipi to discover, express and share their stories in the language they love.

SinoUnited Health

Series B in 2019
SinoUnited Health, a medical centre, provides sports medicine, physical therapy, pain management, orthopaedic, and neurology services in China. Its services also include foot and ankle center, acupuncture, chronic pain, movement disorders, migraine, tremor, electromyography, balance and ambulation training, home exercise instruction, manual therapy, post stroke care, post herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. The company was founded in 2004 and is based in Shanghai, China.

LetsGetChecked

Series B in 2019
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

Coffee Box

Series B in 2019
Coffee Box is a coffee chain brand that provides express delivery services.

INXX

Series B in 2019
Hangzhou INXX Fashion Co,. Ltd. retails apparels and accessories through the Internet. The company is based in Hangzhou, China.

Anxin Doctor

Series B in 2019
Anxin Doctor is a mobile maternal and pediatric health platform that connects patients with obstetrics, gynecology doctors and pediatrics doctors.

Abbisko Therapeutics

Series B in 2019
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

Emergen

Series B in 2019
Zhejiang Zhichang Group is a cluster of robots and intelligent manufacturing enterprises founded by Dr. Gan Middle School, the first batch of national “Thousand Talents Program” experts. It has two independent core technologies: distributed intelligent robot controller and HCPS intelligent intellectual network. Three single-arm robots and smart factory eco-networks are three high-end intelligent manufacturing business areas. Committed to the development of robotic products with independent intellectual property rights, breaking the monopoly of foreign brands in the field of key components of robots, and truly realizing the national dream of "intellectual creation".

RedDoorz

Series B in 2019
Reddoorz PT owns and operates an online platform that helps travelers discover a network of branded budget hotels in South East Asia. It offers RedDoorz, a platform that also helps hoteliers and guest house owners to showcase their property in its platform, allowing them to reach out to larger audiences, increase their distribution, earn a brand name, and streamline operations. The company was founded in 2015 and is based in Jakarta, Indonesia.

Xiaobu

Series B in 2019
Sharp Network is an operator of news App based on recommendation engine focusing on south-east Asia market. The App was first launched in Vietnam, whose people have on average the highest education level and the best consumption .
NASN Automotive Electronics is committed to providing advanced and complete chassis electronic control products, ADAS and autonomous driving related core technologies for the Chinese automotive market. The main products include NBooster intelligent brake system, brushless electric steering EPS controller and wire control system. It is a scientific and technological innovation enterprise integrating R&D, production and sales.
Suzhou Connect Biopharmaceuticals, Ltd., a clinical-stage company, discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products in pipeline includes CBP-307, an orally-active, second-generation S1P1 agonist for the treatment of a range of autoimmune diseases, including inflammatory bowel disease, graft-versus-host disease, psoriasis, and multiple sclerosis; CBP-174 for allergic rhinitis and atopic dermatitis; and CBP-201, a novel monoclonal antibody for the treatment of atopic dermatitis, asthma, and other types of allergic inflammation. The company is headquartered in Taicang, China with operations in Melbourne and San Diego.

Antengene Corporation

Series B in 2019
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research and drug production, enabling physicians to meet unmet medical needs in Asia.

ABC Fintech

Series B in 2018
ABC Fintech provides AI-driven cloud services for financial professionals. Its products, Modeling.ai and Eversight.ai, can improve the efficiency of how equity research and investment decisions are made in financial institutions, as well as to predict future trend. The company was founded in 2016 by Yongzhi Yang, who is also the founder and CEO of MoboTap Inc, the company behind Dolphin Browser. So far, ABC Fintech has raised a total of $60 million USD from Qiming Venture Partners, Source Code Capital, SIG Asia Investment, Welight Capital, and MindWorks Ventures.

WorkTrans

Series B in 2018
Shanghai WorkTrans Information Technology Co., Ltd. develops human resource (HR) management software. The company's software solution tracks and analyzes enterprise resource planning (ERP) data and employee performance to estimate the number of work hours and employee skills required in the next phase. It also develops an integrated personnel management platform that integrates payroll, rosters, recruitment, and training solutions. The company was founded in 2015 and is based in Shanghai, China.

Luc Therapeutics

Series B in 2018
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. It was founded in 2010 and headquartered in Cambridge, Massachusetts.

Haoyiku

Series B in 2018
Founded in 2017, Webuy/Jingling Group is a social e-commerce company which owns brands including Shaking Baby (甩甩宝宝), Haoyiku (好衣库) and 芝麻云仓. Webuy Group is a community-based e-commerce platform. It enables merchants to share links to sale items in the app to WeChat, China's most popular social media app, where shoppers can directly make their purchases.

Eigen

Series B in 2018
Eigen is applying the latest AI technologies to variety of business domains, making AI the center of thegravity in industrial evolutions.

Haoyiku

Series B in 2018
Founded in 2017, Webuy/Jingling Group is a social e-commerce company which owns brands including Shaking Baby (甩甩宝宝), Haoyiku (好衣库) and 芝麻云仓. Webuy Group is a community-based e-commerce platform. It enables merchants to share links to sale items in the app to WeChat, China's most popular social media app, where shoppers can directly make their purchases.

Shiyunji

Series B in 2018
Shiyunji doing business as Chomp Cloud, operates a food court that uses mobile and cloud technology to streamline both sales and purchasing. The company has also developed a proprietary software-as a-service (SaaS) which collects orders and distributes them to the correct food vendor, helping them streamline transactions. Additionally, It also provides hardware, software solutions, store operation, brand promotion, and infrastructural services. The company was founded in 2016 and is based in Nanjing, China.

DST Car

Series B in 2018
DiShangTie Car Rental (Shenzhen) Co., Ltd. offers rental and maintenance service for commercial electric vehicles (EVs) for passengers and cargo transportation in China. It manufactures electric car charging stations. DiShangTie Car Rental (Shenzhen) Co., Ltd. was founded in 2015 and is based in Shenzhen, China.

DST Car

Series B in 2018
DiShangTie Car Rental (Shenzhen) Co., Ltd. offers rental and maintenance service for commercial electric vehicles (EVs) for passengers and cargo transportation in China. It manufactures electric car charging stations. DiShangTie Car Rental (Shenzhen) Co., Ltd. was founded in 2015 and is based in Shenzhen, China.

CardiaLen

Series B in 2018
Cardialen, Inc., a medical device company that develops a therapy system that detects and treats atrial fibrillation, rapid ventricular tachycardia, and ventricular fibrillation. It offers an implantable device to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.